GGrantIndex
← Search

ACTG A5103:Protease Inhibitor-Sparing Regimens to Improve Metabolic Abnormalitie

$791M01FY2004RRNIH

New York University School Of Medicine, New York NY

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →